Genomic instability is a characteristic of practically all human cancers. Recent results generated by members of this Consortium suggest that signs of genomic instability are evident from the very beginning of human cancer develop...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
TELOMERES
Genome wide identification of factors controlling the telome...
1M€
Cerrado
RecInRep
Beyond double strand break repair specific mechanisms of ho...
175K€
Cerrado
RSHEALTH
Investigating the causes and consequences of replication str...
2M€
Cerrado
PID2020-116003GB-I00
GENOMICA AVANZADA PARA EL ESTUDIO DE LA INTEGRIDAD DE CROMOS...
272K€
Cerrado
BFU2010-16372
ROTURAS DE ADN ASOCIADAS A REPLICACION Y REPARACION POR RECO...
835K€
Cerrado
SAF2013-49149-R
PREVENCION DE INESTABILIDAD GENOMICA Y CANCER: MODIFICACIONE...
Cerrado
Información proyecto GENICA
Líder del proyecto
UNIVERSITE DE GENEVE
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
5M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Genomic instability is a characteristic of practically all human cancers. Recent results generated by members of this Consortium suggest that signs of genomic instability are evident from the very beginning of human cancer development, even in precancerous lesions. In these early lesions, the genomic instability affects primarily specific genomic loci, called common fragile sites. Because common fragile sites are very sensitive to perturbations in DNA replication, we proposed that cancer development from its very beginning is associated with DNA replication stress. A separate set of observations focused on telomeres and showed that short telomeres mimick DNA ends, activate the DNA damage checkpoint and promote genomic instability and cancer development. We propose here to study the role of DNA replication stress and short telomeres on driving genomic instability particularly in human precancerous lesions. Our studies will investigate the most common forms of cancer in the EU and will benefit from access to some of the largest databases of cancerous and precancerous lesions in Europe. Genomic instability will be explored using high resolution genomic arrays and the data will be correlated to clinical information on tumor progression. Further, analysis of proteins and genes involved in the cellular response to DNA replication stress and short telomeres will be explored using high throughput and targeted approaches and will be used to identify novel targets for cancer therapy.